Company Research Report: DCVC

1. Company Overview

• Name: Data Collective Venture Capital (DCVC)

• Mission:

DCVC aims to support deep tech founders pushing the limits of emerging technologies to solve trillion-dollar problems that matter. The firm is committed to improving the quality of life globally by addressing significant challenges such as climate change, human health, industrial transformation, and more.

• Founded:

DCVC was established in 2010.

• Founders:

The company was co-founded by Matt Ocko and Zachary Bogue.

• Key People:

• Matt Ocko, Co-Founder and Managing Partner

• Zachary Bogue, Co-Founder and Managing Partner

• Dr. John Hamer, Managing Partner

• Dr. Kiersten Stead, Managing Partner

• Headquarters:

• Palo Alto, California

• San Francisco, California

• Number of Employees:

Approximately 45 team members.

• Revenue:

No information is available.

• What is the company known for:

DCVC is recognized for its investment in deep tech companies, leveraging AI and computational technologies to solve substantial real-world problems across various industries. The company has been a pioneer in the venture capital field by focusing on deep tech long before it became a recognized specialty.

2. Products

• What products do they offer:

DCVC itself does not offer products in a traditional sense. However, it invests in companies that create innovative products and technologies across different sectors.

• High-level description and key features:

• DCVC Climate: Focuses on climate-related investments to decarbonize high-emission industries and accelerate the energy transition.

• DCVC Bio: Concentrates on computational biology to enhance human health, agriculture, and material production using data sciences and AI.

• Deep Tech Opportunities Report: DCVC publishes reports outlining compelling investment opportunities and technological advancements.

3. Recent Developments

• Recent Developments and New Products:

• In September 2024, DCVC closed over $700 million in new funds, launching its first dedicated Climate fund and the latest DCVC Bio fund.

• CH4 Global opened the world's first commercial-scale Asparagopsis production facility, a significant milestone for reducing livestock methane emissions.

• Circularity Fuels was incubated by DCVC to convert atmospheric CO2 into ultra-pure methane, utilizing renewable energy efficiently.

• New Features Added to Existing Products:

• For its portfolio companies, DCVC is involved in supporting expansions such as the scaling of CH4 Global’s EcoPark facility to meet increasing demand for Methane Tamer, a feed supplement from seaweed.

• New Partnerships:

• CH4 Global announced partnerships with Chipotle and Mitsubishi to advance its Methane Tamer product in global markets.

• Relation Therapeutics partnered with GSK to develop treatments targeting fibrosis and osteoarthritis, receiving up to $108 million in upfront and potential collaboration payments.

Conclusion

DCVC continues to demonstrate a strategic commitment to leveraging deep tech investments as a mechanism for solving some of the world's most pressing challenges. The firm's focus on innovations in climate technology, human health, and industrial efficiency underscores its impact in advancing global resilience and sustainability. Through its substantial investments and partnerships, DCVC is poised to influence significant advancements across myriad industries.